“A Food and Drug Administration official recommended approving puberty blockers for youth with gender dysphoria while acknowledging that a study showed the drugs were associated with an ‘increased risk in depression and suicidality,’ according to internal emails released by America First Legal.”
Read the full story on NewsMax here.
Follow us on social media for the latest updates on America First Legal’s fight to protect your constitutional rights!
X, Facebook, GETTR, Instagram, Truth Social
For press inquiries, please contact [email protected].
